The United States Patent and Trademark Office (USPTO) has granted patent US12582669B2, titled "Composition controlling pharmacokinetics in the body." The patent, assigned to the KAWASAKI INSTITUTE OF INDUSTRIAL PROMOTION, covers a composition containing a polyvalent cation as an active ingredient for controlling pharmacokinetics, as well as a method for controlling pharmacokinetics using such a cation. The patent was granted on March 24, 2026, with a filing date of March 4, 2024, and application number 18594618.

This patent grant represents a new intellectual property right for the assignee, potentially impacting future drug development and manufacturing processes related to pharmacokinetic control. While this is a patent grant and not a regulatory rule imposing direct compliance obligations on other entities, it signifies innovation in the pharmaceutical space. Companies operating in drug development and manufacturing should be aware of this patent's existence, particularly if their activities involve similar compositions or methods, to avoid potential infringement issues.